2001
$3.2M
from 3 investors over 3 rounds
DecImmune Therapeutics, Inc. raised $2.3M on February 26, 2013
Investors: Astellas Venture Capital L.L.C. and Broadview Ventures Inc
DecImmune Therapeutics, Inc. raised $3.2M on September 27, 2010
Investors: Astellas Venture Capital L.L.C.